| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5190137
Max Phase: Preclinical
Molecular Formula: C15H12N2O4S
Molecular Weight: 316.34
Associated Items:
Representations
Canonical SMILES: O=C(NC(=S)Nc1cccc(O)c1)c1ccc2c(c1)OCO2
Standard InChI: InChI=1S/C15H12N2O4S/c18-11-3-1-2-10(7-11)16-15(22)17-14(19)9-4-5-12-13(6-9)21-8-20-12/h1-7,18H,8H2,(H2,16,17,19,22)
Standard InChI Key: CSADTVGKUNTNCI-UHFFFAOYSA-N
Associated Targets(Human)
HeLa (62764 Activities)
HEK293 (82097 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
P2RX2 Tchem P2X purinoceptor 2 (190 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
P2RX4 Tchem P2X purinoceptor 4 (516 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
P2RX5 Tchem P2X purinoceptor 5 (52 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
P2RX7 Tchem P2X purinoceptor 7 (5534 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 316.34 | Molecular Weight (Monoisotopic): 316.0518 | AlogP: 2.25 | #Rotatable Bonds: 2 |
| Polar Surface Area: 79.82 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.20 | CX Basic pKa: | CX LogP: 2.93 | CX LogD: 2.92 |
| Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.74 | Np Likeness Score: -1.28 |
References
| 1. Mahmood A, Villinger A, Iqbal J.. (2022) Therapeutic potentials and structure-activity relationship of 1,3-benzodioxole N-carbamothioyl carboxamide derivatives as selective and potent antagonists of P2X4 and P2X7 receptors., 238 [PMID:35660250] [10.1016/j.ejmech.2022.114491] |
Source
Source(1):